Ipilimumab trials for Melanoma Stage IV

All Ipilimumab trials · All Melanoma Stage IV trials

Phase breakdown

Recruiting trials studying Ipilimumab for Melanoma Stage IV

• Anti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study)
  NCT03340129 · Phase: Phase 2 · Ages: 18 Years to 120 Years · Sex: All (male and female) · 9 locations
• IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients
  NCT04562129 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma
  NCT06295159 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Ipilimumab for Melanoma Stage IV?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.